SyntheticMR announces FDA clearance of new SyMRI release
SyntheticMR AB announced today that its new SyMRI version was cleared by FDA for head imaging with significant improvements, including image quality and added functionality to the reference curves. The work to get FDA clearance for the different applications of MSK continues. “We are pleased with the FDA approval of our new SyMRI version,” says Ulrik Harrysson, CEO at SyntheticMR AB. “SyntheticMR’s ambition is to broaden the application of SyMRI to additional anatomies. It is with full commitment and even greater focus that we continue to pursue and develop our innovative product